Feinstein Institute for Medical research

Manhasset, New York 11030-3816

1 studies enrolling now · 39 studies all time

What they study most

Active Systemic Lupus Erythematosus, Alzheimer's Disease, Aphasia, Arthritis, Rheumatoid, Blood Biomarkers, COVID-19, Cerebrovascular Accident (CVA), Chronic Lymphocytic Leukemia, Crohn's Disease, Cytokine Response to Vagus Nerve Stimulation, Early Alzheimer´s Disease, Healthy

Studies at this site

• A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) — Completed
• COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders — Stopped early
• A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease — Stopped early
• Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis — Completed
• Ultrasound of the Spleen Utilizing Low-energy (Diagnostic Level) Insonification. — Starting soon
• Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) — Completed
• A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) — Completed
• Study of VIB7734 for the Treatment of Moderate to Severely Active SLE — Completed
• Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus — Stopped early
• Hydroxyurea Adherence for Personal Best in Sickle Cell Disease (HABIT): Efficacy Trial — Completed
• Relationship Between Data Obtained With the LuGENE® Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With SLE (ReLATE) — Status unconfirmed
• A Study Evaluating Tocilizumab in Pediatric Patients Hospitalized With COVID-19 — Completed
• B-type Chronic Lymphocytic Leukemia (B-CLL) Subgroups: Maturation Stage and Gene Expression — Completed
• B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging — Completed
• An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis — Completed
• Omega-3 Replacement With Krill Oil in Disease Management of SLE — Completed
• Anti-TNF Agents for the Treatment of Rheumatoid Arthritis — Completed
• Transcutaneous Vagus Nerve Stimulation (tVNS) and Robotic Training to Improve Arm Function After Stroke — Completed
• Robots Paired With tDCS in Stroke Recovery — Completed
• The Role of Trans-spinal Direct Current Stimulation (tsDCS) in Treating Patients With Hand Spasticity After Stroke — Completed
• Evaluating Anodal tDCS Preceding Aphasia Therapy — Stopped early
• A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE) — Completed
• Characterization of Proliferating Compartment in B-Cell Patients and in Healthy Aging Subjects — Completed
• Direct Measurement of Leukemic Cell Turnover (Synthesis and Removal) in Patients With Chronic Lymphocytic Leukemia (CLL) Using Deuterated Water — Completed
• Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE) — Stopped early
• A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus. — Completed
• A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus — Completed
• A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus — Completed
• Iron Overload in Pediatric Oncology Patients — Completed
• The General Use of Robots in Stroke Recovery — Withdrawn before enrolling
• Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus — Completed
• T and B Cell Responses in Autoimmune Diseases — Stopped early
• Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE) — Completed
• Investigation of Systemic Metal Ion Concentration Following a Ceramic-on-metal Total Hip Arthroplasty — Withdrawn before enrolling
• Genetic Registry for Rheumatoid Arthritis — Completed
• Investigations Regarding B-cell Subsets in Humans — Completed
• Effects of Auricular Vagus Nerve Stimulation on the Pro-inflammatory Cytokine Response in Healthy Adults — Completed
• The Role of ITGAM in Systemic Lupus Erythematosus — Completed
• Study of LJP 394 in Lupus Patients With History of Renal Disease — Stopped early